ReviewDer Urologe. Ausg. A2022
[Opportunities and risks of telemedicine in urology].
Review in Der Urologe. Ausg. A, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Use of telemedicine continues to increase in Germany. The legal framework has been expedited by several laws, such as the Appointment Service and Supply Act (TSVG), Digital Care Act (DVG), Patient Data Protection Act (PDSG) and Hospital Future Act (KHZG). The first digital health applications (DiGAs) that can be prescribed by doctors and will be reimbursed by medical insurance have entered the market and many more will follow, including urological applications. Video consultations have seen a remarkable increase driven by the Corona pandemic and will continue to be fully implemented in daily work. Electronic patient records will also be widely available within the next few years and will have a positive influence on efficiency in health care, as all steps in the treatment process will be digitalized. This will be supported by the e‑prescription and customer-friendly pathways of distribution of their medications. The most important challenges that hopefully do not inhibit the very much needed progress in the digitalization of healthcare are data protection and the compatibility between systems. Driven by the advances in digital healthcare and urology, urologists will experience a significant gain of efficiency in daily work.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.